Unlocking the European Market for Your Rare Disorder Assets


Navigate the complexities of the European rare disorders market with our unmatched expertise

Strategic Advisory and Consulting

We provide tailored strategic guidance to help you develop an accelerated market entry strategy and maximize the commercial potential of your rare disorder assets.

Partnering

Our extensive industry connections enable us to identify and connect you with potential partners for licensing, co-development, and commercialization opportunities. We assist you in navigating the world of rare disorder financing, connecting you with potential investors and financing partners to accelerate your development and
commercialization efforts.

Executive and Board Search

Navigating the intricate landscape of the European rare and orphan disorders pharmaceutical and biotechnology industry demands exceptional leadership. Our unparalleled industry connections empower us to identify and recruit the most astute minds, ensuring your organization commands the expertise necessary to excel in this specialized domain.

Partner Forward: Accelerator Program

Our bespoke Accelerator Program, Partner Forward, provides the support, resources, and access to our seasoned industry leaders to fast-track your rare disorder asset development and commercialization, from early-stage innovation to successful market launch.

Discover our story

More about who we are, why we started, and what we can do for you.

Two Co Workers Having a Chat In The Office

Meet our experts

Industry’s rare disorders experts creating exceptional outcomes

Taking it forward

Accelerating Your Innovation’s Journey to Market with our bespoke Accelerator Program.

Partner Forward Logo

Taking it forward

Accelerating Your Innovation’s Journey to Market with our bespoke Accelerator Program.

Read our

latest insights

Navigating Gene Therapy Commercialization in Europe: A Q&A with Novartis’ Joshi Venugopal

Navigating Gene Therapy Commercialization in Europe A Q&A with Joshi Venugopal, General Manager of Gene Therapies and Rare Diseases, Europe Opinions expressed here are personal and not that of Novartis* Gene therapies hold immense promise for revolutionizing the treatment of rare diseases, offering potential cures where previously only symptom management was possible. However, the path […]

Rare Disease Clinical Trials

RARE DISEASE CLINICAL TRIALS: A Collaborative Approach to Design and Execution

Rare Disease Clinical Trials A Collaborative Approach to Design and Execution Patients who suffer from rare diseases need access to effective and safe medications. Given the low incidence of the diseases, the collaboration between regulatory authorities, producers, insurances, and market access teams is essential for pharmaceutical companies seeking to bring new medications to patients and […]

Navigating Gene Therapy Commercialization in Europe: A Q&A with Novartis’ Joshi Venugopal

Navigating Gene Therapy Commercialization in Europe: A Q&A with Novartis’ Joshi Venugopal

Navigating Gene Therapy Commercialization in Europe A Q&A with Joshi Venugopal, General Manager of Gene Therapies and Rare Diseases, Europe Opinions expressed here are personal and not that of Novartis* Gene therapies…

RARE DISEASE CLINICAL TRIALS: A Collaborative Approach to Design and Execution

RARE DISEASE CLINICAL TRIALS: A Collaborative Approach to Design and Execution

Rare Disease Clinical Trials A Collaborative Approach to Design and Execution Patients who suffer from rare diseases need access to effective and safe medications. Given the low incidence of the diseases, the…